Literature DB >> 12481980

I. Arginine.

H Tapiero1, G Mathé, P Couvreur, K D Tew.   

Abstract

L-Arginine (Arg) is classified as an essential amino acid for birds, carnivores and young mammals and a conditionally essential amino acid for adults. It is converted by arginase to L-ornithine, a precursor of polyamines and urea, which is important in the urea cycle. Arg serves as a precursor for creatine, which plays an essential role in the energy metabolism of muscle, nerve and testis and accounts for Arg catabolism and for the synthesis of agmatine and proteins. Via its ability to increase growth hormone secretion it influences immune function. Depending on nutritional status and developmental stage, normal plasma Arg concentrations in humans and animals range from 95 to 250 micromol/l. Systemic or oral Arg administration has been shown to improve cardiovascular function and reduce myocardial ischemia in coronary artery disease patients. It reduces blood pressure and renal vascular resistance in essential hypertensive patients with normal or insufficient renal function. Although Arg plasma concentrations are not altered in hypercholesterolemic individuals, oral or intravenous Arg administration can reverse endothelial dysfunction in hypercholesterolemic patients and in cigarette smokers. The main importance of Arg is attributed to its role as a precursor for the synthesis of nitric oxide (NO), a free radical molecule that is synthesized in all mammalian cells from L-Arg by NO synthase (NOS). NO appears to be a major form of the endothelium-derived relaxing factor (EDRF). NO and EDRF share similar chemical and pharmacological properties and are derived from the oxidation of a terminal guanidine group of L-Arg. Various mechanisms have been implicated in the defect in vascular relaxation. These include, increased diffusional barrier for NO, L-Arg depletion, altered levels of reactive oxygen, inactivation of NO by superoxide anions (O2-). The independent reactions of O2-, NO and their reaction yielding peroxynitrite are critical in the initiation and maintenance of the atherosclerotic state and contribute to the defect in vasorelaxation. NO also plays a role as a neurotransmitter, mediator of immune response and as signaling molecule. The NO synthesized by iNOS in macrophages contributes to their cytotoxic activity against tumor cells, bacteria and protozoa. Our aim here is to review on some amino acids with high functional priority such as Arg and to define their effective activity in human health and pathologies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12481980     DOI: 10.1016/s0753-3322(02)00284-6

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  45 in total

Review 1.  Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis.

Authors:  Dmitri Y Boudko
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-15       Impact factor: 3.205

Review 2.  Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights.

Authors:  Stephen L Chan; Winnie Yeo
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

Review 3.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

4.  Exogenous nitric oxide donor and arginine provide protection against short-term drought stress in wheat seedlings.

Authors:  Mirza Hasanuzzaman; Kamrun Nahar; Anisur Rahman; Masashi Inafuku; Hirosuke Oku; Masayuki Fujita
Journal:  Physiol Mol Biol Plants       Date:  2018-05-19

5.  Administering the Optimum Dose of l-Arginine in Regional Tumor Therapy.

Authors:  Emad Y Moawad
Journal:  Indian J Clin Biochem       Date:  2013-09-15

6.  PIK3CA mutant tumors depend on oxoglutarate dehydrogenase.

Authors:  Nina Ilic; Kıvanç Birsoy; Andrew J Aguirre; Nora Kory; Michael E Pacold; Shambhavi Singh; Susan E Moody; Joseph D DeAngelo; Nicole A Spardy; Elizaveta Freinkman; Barbara A Weir; Aviad Tsherniak; Glenn S Cowley; David E Root; John M Asara; Francisca Vazquez; Hans R Widlund; David M Sabatini; William C Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

Review 7.  The Reactive Species Interactome: Evolutionary Emergence, Biological Significance, and Opportunities for Redox Metabolomics and Personalized Medicine.

Authors:  Miriam M Cortese-Krott; Anne Koning; Gunter G C Kuhnle; Peter Nagy; Christopher L Bianco; Andreas Pasch; David A Wink; Jon M Fukuto; Alan A Jackson; Harry van Goor; Kenneth R Olson; Martin Feelisch
Journal:  Antioxid Redox Signal       Date:  2017-06-06       Impact factor: 8.401

8.  A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients.

Authors:  T-S Yang; S-N Lu; Y Chao; I-S Sheen; C-C Lin; T-E Wang; S-C Chen; J-H Wang; L-Y Liao; J A Thomson; J Wang-Peng; P-J Chen; L-T Chen
Journal:  Br J Cancer       Date:  2010-08-31       Impact factor: 7.640

9.  Lipid metabolism in rats is modified by nitric oxide availability through a Ca++-dependent mechanism.

Authors:  Carlos A Marra; Julio Nella; Damián Manti; María J T de Alaniz
Journal:  Lipids       Date:  2007-01-19       Impact factor: 1.880

10.  Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice.

Authors:  Alexander Kaminski; Christiane Backhaus Pohl; Christoph Sponholz; Nan Ma; Christof Stamm; Brigitte Vollmar; Gustav Steinhoff
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.